Insights by Tag:

Covid-19

Market
Best performing products Europe 2023: autocalls remain in charge

19 Dec 2023

Best performing products Europe 2023: autocalls remain in charge

SRP reviews some of the best-performing products across European markets in 2023.

Market
Latest: Leonteq settles legacy litigation on commissions

03 Jan 2023

Latest: Leonteq settles legacy litigation on commissions

The Swiss structured products specialist firm rejected the claims brought forward by Old Mutual International (OMI) in 2018.

Technology
Exclusive: BBVA adds FX to ePricer platform

28 Nov 2022

Exclusive: BBVA adds FX to ePricer platform

The Spanish bank continues to build its investment solutions business globally by leveraging areas and asset classes with more of a regional focus.

Market Reviews
Taiwan Market Review, May 2022: 34% drop in issuance

30 Jun 2022

Taiwan Market Review, May 2022: 34% drop in issuance

There were 943 products with strike dates in May.

Market
SRP in brief: off to a good start

23 May 2022

SRP in brief: off to a good start

Position changes at Citi, global issuance volumes and fines in the US all featured in the headlines in the past week.

Analysis
Analysis: coping with market corrections

16 Feb 2022

Analysis: coping with market corrections

As has been widely reported in the financial press recently most major markets have experienced a significant correction from the highs posted at the end of 2021.

Products
Inflation and structured products

02 Feb 2022

Inflation and structured products

Inflationary pressures dominated the world economy in the 1970s.

Events
SRP Americas 2021: the vision for a sustainable future of the industry

30 Sep 2021

SRP Americas 2021: the vision for a sustainable future of the industry

This years’ flagship panel discussion looked at the transition from the pre-covid world to the new normal.

Products
North America: Eurostoxx 50 recovers from Covid shockwave

17 Aug 2021

North America: Eurostoxx 50 recovers from Covid shockwave

The SRP database shows a significant boost in structured products tied to Eurostoxx 50 in the North American market with 2021 sales to-date totalling US$1.4 billion, swiftly gaining on 2020’s overall value of US$1.7 billion.

Products
UBS: investors have started to question the 60/40 paradigm

17 Aug 2021

UBS: investors have started to question the 60/40 paradigm

In the second part of this article, Spyros Mesomeris (pictured), global head QIS structuring at UBS, talks about the revival of QIS as an alternative to address the shortcomings of the 60/40 approach, and the need to offer tailored solutions to attract new clients.

Products
UBS: investors understand there are better returns beyond standard benchmark

16 Aug 2021

UBS: investors understand there are better returns beyond standard benchmark

In this series of articles, we look at how investors are reacting to volatility and inflation, and what trades are being developed by QIS teams to capitalise on market trends.

Events
SRP Apac 2021: diversification and personalization for UHNW investors

23 Jun 2021

SRP Apac 2021: diversification and personalization for UHNW investors

The increase in volatility since the outbreak of Covid-19 has shifted the attention towards market neutral strategies and structured products as a way for HNWIs to access new opportunities such as IPOs.